Home » Topics » Conferences

Conferences
RSS

Santen characterizes dual NEP/ACE inhibitor

March 24, 1997

Fujisawa describes compound for autoimmune diseases

March 24, 1997

New antiinflammatory agent from Yakult Honsha

March 24, 1997

Dainippon presents broad-spectrum antiemetic agent

March 24, 1997

Fujisawa presents selective, nonpeptide thrombin receptor inhibitor

March 21, 1997

SA-7060: a dual NEP and ACE inhibitor from Santen

March 20, 1997

Sumitomo presents new Na+/H+-exchange inhibitor

March 20, 1997

Meiji Seika's new orally active gpIIb/IIIa antagonist

March 20, 1997

Agent for atopic dermatitis reported by Terumo

March 20, 1997

Highly potent and selective ETA antagonist from Tanabe Seiyaku

March 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...